Hanna Gaggin, MD, MPH
Dr. Gaggin is a clinical investigator, educator, and cardiologist at Massachusetts General Hospital and Harvard Medical School who focuses on evidence-based application of Precision Medicine in Cardiology – how best to target treatment to the individual to optimize clinical benefit and minimize adverse effects.
She is also interested in improving the efficiency of clinical trials and participates in multi-center clinical trials including registries, diagnostic studies, and drug trials. She serves as an Editorial Consultant for the Journal of the American College of Cardiology: Heart Failure.
Dr. Gaggin graduated from the Eastern Virginia Medical School in 2003. She completed her Internal Medicine residency at the University of Virginia Health System, followed by an MPH at Harvard School of Public Health with a concentration in Quantitative Methods in 2007. She completed her clinical cardiology fellowship at the University of Pittsburgh Medical Center and clinical research fellowship at MGH and joined the faculty at MGH in 2012.
Representative Publications:
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction
Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure
Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis
Associations Between Psychological Constructs and Cardiac Biomarkers After Acute Coronary Syndrome
